Measuring Our Impact

Medicines 360 logo

When women can access affordable contraception, they can live their best and fullest lives. As part of our pioneering non-profit pharmaceutical business model, Medicines360 makes its product available at a  price substantially below the 340B ceiling price set by statute to clinics participating in the 340B Drug Pricing Program. A key component of measuring our […]

Pioneering the Nonprofit Pharmaceutical Industry

Medicines 360 logo

Medicines360 is a nonprofit women’s health pharmaceutical company in San Francisco. As a nonprofit, we answer to our mission: to remove cost as a barrier to health by developing and providing quality, affordable women’s health products. We were founded in 2009 and brought our first product to the U.S. market in 2015. We’re proud of […]

Medicines360 Commemorates World Contraception Day 2019

Medicines 360 logo

As Medicines360 commemorates World Contraception Day 2019, we recognize the work we’ve done and the work we have left to do. Too many women in the U.S. and across the globe still have difficulty accessing the full range of contraceptive options to live their lives on their own terms. In addition to improving contraceptive access […]

Medicines360 Welcomes Margot Fahnestock as Vice President of Strategic Development

Medicines 360 logo

Medicines360 is delighted to announce that Margot Fahnestock has joined our team as Vice President of Strategic Development.  Margot will be responsible for planning, organizing, and implementing all of our high-impact strategic programming and fundraising efforts both in the U.S. and globally. Before Medicines360, Margot served as a Program Officer in the William and Flora […]

Medicines360 Statement on Title X Rule Change

Medicines 360 logo

As the leading nonprofit pharmaceutical company addressing women’s most pressing health needs, Medicines360 has continuously and strongly opposed the new rule restricting Title X-funded clinics from providing patients with medically accurate and comprehensive health information. Our concerns about this rule’s impact on the availability, accessibility and affordability of quality women’s health and family planning services […]

AVIBELA™ Launches in Zambia

Medicines 360 logo

Medicines360 is excited to announce that Avibela™, our 52 mg levonorgestrel intrauterine device (IUD), has launched in Zambia! AVIBELA is the first hormonal IUD registered in Zambia. AVIBELA is not indicated for use in the United States. Through the global FP2020 initiative, the Zambian government has committed to improving sustainable access to family planning. In alignment […]

Medicines360 Announces Collaborative Research to Increase LARC Access in FQHCs

Medicines 360 logo

Federally Qualified Health Centers (FQHCs) are community-based providers that exist to meet patients where they live and provide the primary care services they need. With approximately 12,000 service delivery sites located across the country. FQHCs serve a large number of both insured and uninsured patients. FQHCs have sliding fee scales for uninsured patients to make […]